160 related articles for article (PubMed ID: 2206791)
1. In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.
Helsby NA; Ward SA; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1990 Aug; 30(2):287-91. PubMed ID: 2206791
[TBL] [Abstract][Full Text] [Related]
2. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
Wright JD; Helsby NA; Ward SA
Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
[TBL] [Abstract][Full Text] [Related]
3. In vitro proguanil activation to cycloguanil is mediated by CYP2C19 and CYP3A4 in adult Chinese liver microsomes.
Lu AH; Shu Y; Huang SL; Wang W; Ou-Yang DS; Zhou HH
Acta Pharmacol Sin; 2000 Aug; 21(8):747-52. PubMed ID: 11501186
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
5. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
Birkett DJ; Rees D; Andersson T; Gonzalez FJ; Miners JO; Veronese ME
Br J Clin Pharmacol; 1994 May; 37(5):413-20. PubMed ID: 8054246
[TBL] [Abstract][Full Text] [Related]
6. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
Coller JK; Somogyi AA; Bochner F
Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y
Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390
[TBL] [Abstract][Full Text] [Related]
9. Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound.
Helsby NA; Ward SA; Parslew RA; Friedmann PS; Rhodes LE
Acta Derm Venereol; 1998 Mar; 78(2):81-3. PubMed ID: 9534880
[TBL] [Abstract][Full Text] [Related]
10. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
Chiba K; Kobayashi K; Manabe K; Tani M; Kamataki T; Ishizaki T
J Pharmacol Exp Ther; 1993 Jul; 266(1):52-9. PubMed ID: 8331574
[TBL] [Abstract][Full Text] [Related]
11. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.
Somogyi AA; Reinhard HA; Bochner F
Br J Clin Pharmacol; 1996 Mar; 41(3):175-9. PubMed ID: 8866915
[TBL] [Abstract][Full Text] [Related]
13. Diazinon is activated by CYP2C19 in human liver.
Kappers WA; Edwards RJ; Murray S; Boobis AR
Toxicol Appl Pharmacol; 2001 Nov; 177(1):68-76. PubMed ID: 11708902
[TBL] [Abstract][Full Text] [Related]
14. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.
Skjelbo E; Mutabingwa TK; Bygbjerg Ib; Nielsen KK; Gram LF; Brøosen K
Clin Pharmacol Ther; 1996 Mar; 59(3):304-11. PubMed ID: 8653993
[TBL] [Abstract][Full Text] [Related]
15. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
[TBL] [Abstract][Full Text] [Related]
16. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.
Shimada T; Misono KS; Guengerich FP
J Biol Chem; 1986 Jan; 261(2):909-21. PubMed ID: 3079764
[TBL] [Abstract][Full Text] [Related]
17. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
Andersson T; Miners JO; Veronese ME; Birkett DJ
Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013
[TBL] [Abstract][Full Text] [Related]
18. Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.
Hall SD; Guengerich FP; Branch RA; Wilkinson GR
J Pharmacol Exp Ther; 1987 Jan; 240(1):216-22. PubMed ID: 2879902
[TBL] [Abstract][Full Text] [Related]
19. A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450.
Shimada T; Shea JP; Guengerich FP
Anal Biochem; 1985 May; 147(1):174-9. PubMed ID: 4025815
[TBL] [Abstract][Full Text] [Related]
20. Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes.
Chiba K; Manabe K; Kobayashi K; Takayama Y; Tani M; Ishizaki T
Eur J Clin Pharmacol; 1993; 44(6):559-62. PubMed ID: 8405013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
